3 buy-rated ASX tech shares with bright futures

The modern economy is becoming more digital every year.

This creates opportunities for companies that sit inside these changes.

But where are the opportunities for investors?

Here are three ASX tech shares that could be well placed for a more digital world.

NextDC Ltd (ASX: NXT)

NextDC gives investors exposure to the physical backbone of the digital economy.

It develops and operates data centres, which are used by businesses, cloud providers, technology companies, and other organisations that need secure and reliable infrastructure for their data and computing workloads.

That makes NextDC a different kind of technology share. It is not selling apps or software. It is providing the highly specialised facilities that help keep the digital world running.

Demand for data centre capacity is being supported by cloud computing, artificial intelligence, enterprise digitisation, and the rising volume of data being created across the economy.

These facilities are difficult to build well. They require large amounts of capital, technical expertise, power access, cooling capability, security, and strong operating standards. That creates a meaningful barrier to entry.

Morgans recently put a buy rating and $18.00 price target on its shares.

Pro Medicus Ltd (ASX: PME)

Pro Medicus is an ASX tech share that gives investors exposure to the digital side of healthcare.

Its Visage platform helps hospitals and radiology groups manage, view, and interpret medical images. That is important because modern healthcare produces enormous amounts of imaging data. Scans need to move quickly, load reliably, and be available to clinicians when decisions are being made.

Pro Medicus has built a strong reputation in this market, particularly with large healthcare networks overseas. Its software is not just a nice extra for its customers. It can sit close to the daily workflow of radiologists and hospitals.

And with the long-term need for better medical imaging infrastructure only likely to increase as healthcare systems become more digital, Pro Medicus appears well-placed for long-term growth.

Bell Potter recently put a buy rating and $226.00 price target on its shares.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is one of the ASX’s strongest enterprise software businesses.

It provides software used by large organisations such as councils, universities, government bodies, and corporations.

These customers need systems that can help manage finance, payroll, planning, assets, projects, and administration. The work happens behind the scenes, but it is essential to how these organisations function.

This gives TechnologyOne an attractive position. Its software can become deeply embedded in customer operations, which can make relationships sticky and support recurring revenue over time.

And with the company’s international expansion gaining momentum, it appears well-placed for growth over the long-term.

Morgan Stanley has an overweight rating and $32.00 price target on its shares.

The post 3 buy-rated ASX tech shares with bright futures appeared first on The Motley Fool Australia.

More reading

• US chip stocks were smashed overnight. So why are ASX tech shares rising?
• Down 16%: What on earth is going on with TechnologyOne shares?
• These ASX shares are riding the AI boom. Investors keep overlooking them
• 5 ASX growth shares I want in my portfolio in FY27
• Where to invest $500 on the ASX right now

Motley Fool contributor James Mickleboro has positions in Nextdc, Pro Medicus, and Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.